Virpax Pharmaceuticals

Virpax Pharmaceuticals Announces Positive Results in Study for Long-Lasting Pain Relief Formulation

BERWYN, PA — Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) has reported encouraging results from a minipig Dose Range Finding (DRF) study for Probudur, its long-acting liposomal bupivacaine injection. Designed to provide …

Virpax Pharmaceuticals Announces Positive Results in Study for Long-Lasting Pain Relief Formulation Read More